Receptor binding and transmission studies of H5N1 influenza virus in mammals

Emerging Microbes and Infections

Volumn 2, Issue 1, 2013, Pages

  Zhao, Hanjun ^a,b   Zhou, Jie ^a   Jiang, Shibo ^c,d   Zheng, Bo Jian ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b The Second People's Hospital of Wuhu   (China)

^c FUDAN UNIVERSITY   (China)

^d NEW YORK BLOOD CENTER   (United States)

Author keywords

H5N1; Influenza A virus; Mammal; Receptor binding; Transmission

Indexed keywords

EID: 84920878316     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2013.89     Document Type: Review

References (62)

1. Sims LD, Domenech J, Benigno C et al. Origin and evolution of highly pathogenic H5N1 avian influenza in Asia. Vet Rec 2005; 157: 159–164.
2. World Health Organization. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO. Geneva: WHO, 2013. Available at http://www.who.int/influenza/human_animal_interface (accessed 8 October 2013).
3. Yuen KY, Chan PK, Peiris M et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467–471.
4. Chan PK. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002; 34 Suppl 2: S58–S64.
5. Chen H, Smith GJ, Zhang SY et al. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 2005; 436: 191–192.
6. Lowen AC, Palese P. Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infect Disord Drug Targets 2007; 7: 318–328.
7. Chou YY, Albrecht RA, Pica N et al. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol 2011; 85: 11235–11241.
8. Imai M, Watanabe T, Hatta M et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012; 486: 420–428.
9. Herfst S, Schrauwen EJA, Linster M et al. Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets. Science 2012; 336: 1534–1541.
10. Baigent SJ, McCauley JW. Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. Bioessays 2003; 25: 657–671.
11. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440: 435–436.
12. Baum LG, Paulson JC. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 1990; 40: 35–38.
13. Ibricevic A, Pekosz A, Walter MJ et al. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 2006; 80: 7469–7480.
14. van Riel D, Munster VJ, de Wit E et al. H5N1 Virus Attachment to Lower Respiratory Tract. Science 2006; 312: 399.
15. Uiprasertkul M, Puthavathana P, Sangsiriwut K et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005; 11: 1036–1041.
16. Beigel JH, Farrar J, Han AM et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 1374–1385.
17. Shinya K, Hatta M, Yamada S et al. Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol 2005; 79: 9926–9932.
18. Gambaryan A, Tuzikov A, Pazynina G, Bovin N, Balish A, Klimov A. Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 2006; 344: 432– 438.
19. Hatta M, Hatta Y, Kim JH et al. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog 2007; 3: 1374–1379.
20. Nicholls JM, Chan MC, Chan WY et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 2007; 13: 147–149.
21. Cunha BA. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 2004; 18: 141–155.
22. Stevens J, Blixt O, Tumpey TM et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006; 312: 404–410.
23. Glaser L, Stevens J, Zamarin D et al. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 2005; 79: 11533–11536.
24. Lindstrom SE, Cox NJ, Klimov A. Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957–1972: evidence for genetic divergence and multiple reassortment events. Virology 2004; 328: 101–119.
25. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994; 205: 17–23.
26. Wang WJ, Lu B, Zhou HL et al. Glycosylation at 158N of the Hemagglutinin Protein and Receptor Binding Specificity Synergistically Affect the Antigenicity and Immunogenicity of a Live Attenuated H5N1 A/Vietnam/1203/2004 Vaccine Virus in Ferrets. J Virol 2010; 84: 6570–6577.
27. Stevens J, Blixt O, Chen LM et al. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol 2008; 381: 1382– 1394.
28. Maines TR, Chen LM, Van Hoeven N et al. Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 2011; 413: 139–147.
29. Yen HL, Lipatov AS, Ilyushina NA et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol 2007; 81: 6890–6898.
30. Naughtin M, Dyason JC, Mardy S, Sorn S, von Itzstein M, Buchy P. Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus. Antimicrob Agents Chemother 2011; 55: 2004– 2010.
31. Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P. The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci USA 2006; 103: 9988–9992.
32. van Riel D, Munster VJ, de Wit E et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007; 171: 1215–1223.
33. Rigoni M, Toffan A, Viale E et al. The mouse model is suitable for the study of viral factors governing transmission and pathogenesis of highly pathogenic avian influenza (HPAI) viruses in mammals. Vet Res 2010; 41: 66.
34. Yen HL, Aldridge JR, Boon AC et al. Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc Natl Acad Sci USA 2009; 106: 286–291.
35. Manz B, Matrosovich M, Bovin N, Schwemmle M. A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice. J Virol 2010; 84: 8316–8321.
36. Yamada S, Suzuki Y, Suzuki T et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006; 444: 378–382.
37. Li Z, Chen H, Jiao P, Deng G et al. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 2005; 79: 12058–12064.
38. Maines TR, Chen LM, Matsuoka Y et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci USA 2006; 103: 12121–12126.
39. Jackson S, Van Hoeven N, Chen LM et al. Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment. J Virol 2009; 83: 8131–8140.
40. Chen LM, Blixt O, Stevens J et al. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology 2012; 422: 105–113.
41. Hinshaw VS, Webster RG, Easterday BC, Bean WJ Jr. Replication of avian influenza A viruses in mammals. Infect Immun 1981; 34: 354–361.
42. Vahlenkamp TW, Harder TC. Influenza virus infections in mammals. Berl Munch Tierarztl Wochenschr 2006; 119: 123–131.
43. Kuiken T, Fouchier R, Rimmelzwaan G, Osterhaus A, Roeder P. Feline friend or potential foe? Nature 2006; 440: 741–742.
44. Rimmelzwaan GF, van Riel D, Baars M et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006; 168: 176–183.
45. Thiry E, Zicola A, Addie D et al. Highly pathogenic avian influenza H5N1 virus in cats and other carnivores. Vet Microbiol 2007; 122: 25–31.
46. Yingst SL, Saad MD, Felt SA. Qinghai-like H5N1 from domestic cats, northern Iraq. Emerg Infect Dis 2006; 12: 1295–1297.
47. Leschnik M, Weikel J, Mostl K et al. Subclinical infection with avian influenza A (H5N1) virus in cats. Emerg Infect Dis 2007; 13: 243–247.
48. Kuiken T, Rimmelzwaan G, van Riel D et al. Avian H5N1 influenza in cats. Science 2004; 306: 241.
49. Ito T, Couceiro JN, Kelm S et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998; 72: 7367–7373.
50. Castrucci MR, Donatelli I, Sidoli L et al. Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology 1993; 193: 503–506.
51. Lipatov AS, Kwon YK, Sarmento LV et al. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog 2008; 4: e1000102.
52. Zhang Y, Zhang QY, Kong HH et al. H5N1 Hybrid Viruses Bearing 2009/H1N1 Virus Genes Transmit in Guinea Pigs by Respiratory Droplet. Science 2013; 340: 1459–1463.
53. Sun YP, Bi YH, Pu J et al. Guinea Pig Model for Evaluating the Potential Public Health Risk of Swine and Avian Influenza Viruses. PLoS ONE 2010; 5: e15537
54. Gao Y, Zhang Y, Shinya K et al. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 2009; 5: e1000709.
55. Rimmelzwaan GF, Kuiken T, van Amerongen G et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 2001; 75: 6687–6691.
56. Kuiken T, Rimmelzwaan GF, Van Amerongen G, Osterhaus AD. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet Pathol 2003; 40: 304–310.
57. Chen Y, Deng W, Jia C, Dai X et al. Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission. Arch Virol 2009; 154: 227– 233.
58. Centers for Disease Control and Prevention. H5N1 Genetic Changes Inventory: A Tool for Influenza Surveillance and Preparedness. Atlanta: CDC, 2013. Available at http://www.cdc.gov/flu/avianflu/h5n1-genetic-changes.htm (accessed 8 August 2013).
59. Xu R, McBride R, Nycholat CM, Paulson JC, Wilson IA. Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. Journal of virology 2012; 86: 982–990.
60. Chan KH, Zhang AJ, To KK et al. Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PloS ONE 2010; 5: e13757.
61. Chen H, Wen X, To KK et al. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis 2010; 201: 1517–1521.
62. Melidou A, Gioula G, Exindari M et al. Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections. Virus research 2010; 151: 192–199.